Rainbow Children’s [RAINBOW] vs Alivus Life Sciences [GLS] Detailed Stock Comparison

Rainbow Children's

NSE

Alivus Life Sciences

NSE

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Rainbow Children's wins in 4 metrics, Alivus Life Sciences wins in 15 metrics, with 0 ties. Alivus Life Sciences appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric	Rainbow Children's	Alivus Life Sciences	Better
P/E Ratio (TTM)	61.72	31.45	Alivus Life Sciences
Price-to-Book Ratio	10.78	5.23	Alivus Life Sciences
Debt-to-Equity Ratio	51.77	0.63	Alivus Life Sciences
PEG Ratio	1.74	22.31	Rainbow Children's
EV/EBITDA	35.24	21.33	Alivus Life Sciences
Profit Margin (TTM)	16.73%	19.21%	Alivus Life Sciences
Operating Margin (TTM)	19.67%	23.53%	Alivus Life Sciences
EBITDA Margin (TTM)	19.67%	23.53%	Alivus Life Sciences
Return on Equity	16.50%	17.18%	Alivus Life Sciences
Return on Assets (TTM)	10.24%	11.43%	Alivus Life Sciences
Free Cash Flow (TTM)	$2.50B	$2.85B	Alivus Life Sciences
Dividend Yield	0.40%	N/A	N/A
1-Year Return	28.41%	-7.41%	Rainbow Children's
Price-to-Sales Ratio (TTM)	10.29	6.03	Alivus Life Sciences
Enterprise Value	$159.04B	$128.55B	Rainbow Children's
EV/Revenue Ratio	10.34	5.83	Alivus Life Sciences
Gross Profit Margin (TTM)	86.54%	55.55%	Rainbow Children's
Revenue per Share (TTM)	$152	$180	Alivus Life Sciences
Earnings per Share (Diluted)	$25.25	$34.48	Alivus Life Sciences
Beta (Stock Volatility)	0.29	0.16	Alivus Life Sciences

Performance

Key Stats

Valuation

Financials

Short Interest

Dividends

Rainbow Children's vs Alivus Life Sciences Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock	1D	1W	1M	3M	6M	YTD
Rainbow Children's	-0.58%	2.16%	5.33%	18.90%	19.88%	2.02%
Alivus Life Sciences	-0.13%	2.78%	-8.22%	-11.90%	-4.53%	-4.71%

Long-term Returns

Stock	1Y	3Y	5Y	10Y	15Y	20Y
Rainbow Children's	28.41%	159.99%	263.44%	263.44%	263.44%	263.44%
Alivus Life Sciences	-7.41%	121.05%	29.63%	29.63%	29.63%	29.63%

Performance Comparison

This comparison requires JavaScript for dynamic charts and real-time data. For complete performance analysis, visit the individual stock overview pages:

Rainbow Children's (RAINBOW): View Full Stock Overview

Alivus Life Sciences (GLS): View Full Stock Overview

The individual stock overview pages contain detailed performance metrics, historical charts, financial data, and comparison tools that work without JavaScript.

Key Performance Metrics Available:

Daily, weekly, monthly, and yearly returns
52-week high and low prices
Market capitalization and valuation ratios
Financial health and profitability metrics
Dividend history and yield information

Performance & Financial Health Analysis: Rainbow Children's vs Alivus Life Sciences

Metric	RAINBOW	GLS
Market Information
Market Cap i	₹158.28B	₹133.05B
Market Cap Category	Mid cap	Mid cap
10 Day Avg. Volume i	137,697	62,523
90 Day Avg. Volume i	180,565	105,168
Last Close	₹1,577.40	₹969.00
52 Week Range	₹1,200.40 - ₹1,709.60	₹850.00 - ₹1,335.10
% from 52W High	-7.73%	-27.42%
All-Time High	₹1,709.60 (Nov 25, 2024)	₹1,335.10 (Sep 16, 2024)
% from All-Time High	-7.73%	-27.42%
Growth Metrics
Quarterly Revenue Growth	0.07%	-0.15%
Quarterly Earnings Growth	0.35%	-0.20%
Financial Health
Profit Margin (TTM) i	0.17%	0.19%
Operating Margin (TTM) i	0.20%	0.24%
Return on Equity (TTM) i	0.17%	0.17%
Debt to Equity (MRQ) i	51.77	0.63
Cash & Liquidity
Book Value per Share (MRQ)	₹144.58	₹207.20
Cash per Share (MRQ)	₹68.30	₹36.43
Operating Cash Flow (TTM) i	₹3.63B	₹4.17B
Levered Free Cash Flow (TTM) i	₹2.43B	₹2.01B
Dividends
Last 12-Month Dividend Yield i	0.40%	N/A
Last 12-Month Dividend i	₹6.00	₹0.00

Valuation & Enterprise Metrics Analysis: Rainbow Children's vs Alivus Life Sciences

Metric	RAINBOW	GLS
Price Ratios
P/E Ratio (TTM) i	61.72	31.45
Forward P/E i	49.44	22.31
PEG Ratio i	1.74	22.31
Price to Sales (TTM) i	10.29	6.03
Price to Book (MRQ) i	10.78	5.23
Market Capitalization
Market Capitalization i	₹158.28B	₹133.05B
Enterprise Value i	₹159.04B	₹128.55B
Enterprise Value Metrics
Enterprise to Revenue i	10.34	5.83
Enterprise to EBITDA i	35.24	21.33
Risk & Other Metrics
Beta i	0.29	0.16
Book Value per Share (MRQ) i	₹144.58	₹207.20

Financial Statements Comparison: Rainbow Children's vs Alivus Life Sciences

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)	RAINBOW	GLS
Revenue/Sales i	₹3.53B	₹6.42B
Cost of Goods Sold i	₹474.98M	₹2.85B
Gross Profit i	₹3.05B	₹3.57B
Research & Development i	N/A	N/A
Operating Income (EBIT) i	₹694.36M	₹1.75B
EBITDA i	₹1.24B	₹2.01B
Pre-Tax Income i	₹713.74M	₹1.85B
Income Tax i	₹175.69M	₹481.87M
Net Income (Profit) i	₹538.05M	₹1.37B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)	RAINBOW	GLS
Cash & Equivalents i	₹202.55M	₹4.46B
Total Current Assets i	₹8.22B	₹20.96B
Total Current Liabilities i	₹1.51B	₹4.64B
Long-Term Debt i	₹7.42B	₹133.80M
Total Shareholders Equity i	₹14.75B	₹25.38B
Retained Earnings i	₹9.57B	N/A
Property, Plant & Equipment i	₹2.55B	₹8.04B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)	RAINBOW	GLS
Operating Cash Flow i	₹241.81M	N/A
Capital Expenditures i	₹-250.87M	N/A
Free Cash Flow i	₹48.93M	N/A
Debt Repayment i	₹380,000	N/A
Common Stock Repurchase i	N/A	N/A

Short Interest & Institutional Ownership Analysis

Metric	RAINBOW	GLS
Shares Short i	N/A	N/A
Short Ratio i	N/A	N/A
Short % of Float i	N/A	N/A
Average Daily Volume (10 Day) i	137,697	62,523
Average Daily Volume (90 Day) i	180,565	105,168
Shares Outstanding i	101.55M	122.53M
Float Shares i	46.85M	30.63M
% Held by Insiders i	0.54%	0.76%
% Held by Institutions i	0.30%	0.07%

Dividend Analysis & Yield Comparison: Rainbow Children's vs Alivus Life Sciences

Metric	RAINBOW	GLS
Last 12-Month Dividend i	₹6.00	₹0.00
Last 12-Month Dividend Yield i	0.40%	N/A
3-Year Avg Annual Dividend i	₹3.67	₹18.00
3-Year Avg Dividend Yield i	0.28%	3.82%
3-Year Total Dividends i	₹11.00	₹54.00
Ex-Dividend Date	Jun 27, 2025	Oct 17, 2023

Rainbow Children's [RAINBOW] vs Alivus Life Sciences [GLS] Detailed Stock Comparison